John Beadle on Aegis Ventures
Episode 5··46 min·Venture studio · Health system partnerships · Company building · Digital health investing
John Beadle is co-founder and managing partner of Aegis Ventures, a venture studio that builds healthcare companies in partnership with large health systems. In this episode he explains why Aegis chose to co found companies rather than only invest, how health system partnerships create distribution that a typical seed startup cannot buy, and how he evaluates whether an idea should become a company at all.
Listen to this episode
Chapters
- 00:00Why a studio instead of a fund
- 06:20Co founding with health systems
- 15:00Picking problems worth a company
- 24:40Recruiting operators into day one
- 33:10How the economics actually work
- 41:00What is overfunded and underfunded in health AI
About the guest
Full transcript
Sathvik Bilakanti: John, most people in your seat raise a fund and write checks. Why build a studio?
John Beadle: Because in healthcare the hardest part is almost never the idea, it is the first ten customers. If you can solve distribution at formation, you change the risk profile of the entire company. We would rather own more of fewer companies where we control the go to market from day one than spray capital and hope a founder cracks health system sales on their own.
Sathvik Bilakanti: What does co founding with a health system actually look like in practice?
John Beadle: We sit with the system's leadership and identify a problem they are willing to commit resources to, not just endorse. Then we form the company with them, with real governance and real data access, and we bring in an operating team. The system becomes the first design partner and the first customer, and they have equity in the outcome, so their incentive is for the company to succeed beyond their own walls.
Sathvik Bilakanti: How do you decide an idea deserves a company rather than a feature?
John Beadle: Three filters. Is the workflow painful enough that someone is already paying for a bad version of it. Is there a durable data or integration advantage we can build. And can the same product serve a second and third system without a rewrite. If a problem fails the third filter, it is a consulting engagement, not a company.
Sathvik Bilakanti: You are recruiting CEOs into companies that do not exist yet. How does that pitch work?
John Beadle: Honestly, it self selects. The people who say yes are operators who have already run a health tech go to market and are tired of spending eighteen months getting a signed pilot. We are offering them a committed customer, capital, and a shared services bench for recruiting, finance, and design. What we are not offering is total control, and that is the trade some people rightly decline.
Sathvik Bilakanti: And the economics?
John Beadle: We take founder level ownership because we are doing founder level work, and the system partner takes meaningful equity for the commitment they are making. Our capital goes further because customer acquisition is cheaper. The honest cost is concentration. We cannot run a hundred experiments, so each company has to be right.
Sathvik Bilakanti: Where is capital going in the wrong direction right now?
John Beadle: There is too much money in thin wrappers around a model that any incumbent can ship as a feature. There is too little in the unglamorous plumbing, identity, data quality, revenue integrity, the systems that make everything else trustworthy. The plumbing companies are harder to build and much harder to displace once they work.
Insights drawing on this conversation
More Care Shift episodes
Care Shift is a healthtech podcast and early stage investment syndicate hosted by Sathvik Bilakanti, co general partner of Vaelion Ventures. Browse all episodes or read more about the show.